These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3535973)
1. Treatment of mania with the cholinomimetic agent RS 86. Krieg JC; Berger M Br J Psychiatry; 1986 May; 148():613. PubMed ID: 3535973 [No Abstract] [Full Text] [Related]
2. RS 86 in manic disorder. van Berkestijn H; van der Meulen LM; Flentge F; Dols L; van den Hoofdakker R Biol Psychiatry; 1990 Jan; 27(1):109-12. PubMed ID: 2404521 [No Abstract] [Full Text] [Related]
3. Cholinergic influence on manic symptoms. Krieg JC; Berger M Clin Neuropharmacol; 1986; 9 Suppl 4():544-6. PubMed ID: 3567961 [No Abstract] [Full Text] [Related]
4. Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism. Noring U; Povlsen UJ; Casey DE; Gerlach J Psychopharmacology (Berl); 1984; 84(4):569-71. PubMed ID: 6152058 [TBL] [Abstract][Full Text] [Related]
5. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86. Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT). Wettstein A; Spiegel R Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959 [TBL] [Abstract][Full Text] [Related]
7. No response to high-dose muscarinic agonist therapy in Alzheimer's disease. Mouradian MM; Mohr E; Williams JA; Chase TN Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057 [TBL] [Abstract][Full Text] [Related]
8. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Hollander E; Davidson M; Mohs RC; Horvath TB; Davis BM; Zemishlany Z; Davis KL Biol Psychiatry; 1987 Sep; 22(9):1067-78. PubMed ID: 3651528 [TBL] [Abstract][Full Text] [Related]
9. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders. Berger M; Riemann D; Krieg C Acta Psychiatr Scand Suppl; 1991; 366():52-60. PubMed ID: 1897376 [TBL] [Abstract][Full Text] [Related]
10. Cholinomimetic drug RS 86, REM sleep, and depression. Berger M; Höchli D; Zulley J; Lauer C; von Zerssen D Lancet; 1985 Jun; 1(8442):1385-6. PubMed ID: 2861327 [No Abstract] [Full Text] [Related]
11. Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep. Foster NL; Aldrich MS; Bluemlein L; White RF; Berent S Neurology; 1989 Feb; 39(2 Pt 1):257-61. PubMed ID: 2644580 [TBL] [Abstract][Full Text] [Related]